Personalized Ex Vivo Drug Screening and Genomics Profiling to Guide Individualized Treatments for Children with Relapsed or Refractory Solid Tumors and Leukemias Grant

date/time interval

  • May 11, 2018 - October 31, 2022

awarded by

administered by

sponsor award ID

  • 8LA05

local award ID

  • AWD000000008540

contributor